HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination

BACKGROUND AND AIMS: Harm reduction strategies have been shown to decrease the incidence of human immunodeficiency virus (HIV) infection in people who inject drugs (PWID), but the results have been inconsistent when it comes to prevention of hepatitis C virus (HCV) infection. We aimed to examine the...

Descripción completa

Detalles Bibliográficos
Autores principales: Valencia La Rosa, Jorge, Ryan, Pablo, Alvaro-Meca, Alejandro, Troya, Jesús, Cuevas, Guillermo, Gutiérrez, Jorge, Moreno, Santiago
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169909/
https://www.ncbi.nlm.nih.gov/pubmed/30281616
http://dx.doi.org/10.1371/journal.pone.0204795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169909/
https://www.ncbi.nlm.nih.gov/pubmed/30281616
http://dx.doi.org/10.1371/journal.pone.0204795

Ejemplares similares